Skip to main content
ClinicalTrials.govcontrolled

LOGiC - Lapatinib Optimization Study in ErbB2 (HER2) Positive Gastric Cancer: A Phase III Global, Blinded Study Designed to Evaluate Clinical Endpoints and Safety of Chemotherapy Plus Lapatinib

ClinicalTrials.gov study NCT00680901. IPD Sharing: YES. Countries: 23. Publications: 2.

ShareScore

40/100

Overall dataset sharing score

Score breakdown

These five areas show where the dataset supports — or may limit — practical reuse.

Stewardship
16
Harmonization
12
Access
4
Reuse readiness
0
Engagement
8

Topics